Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany iito 600x60px
Document › Details

Siemens AG. (11/29/17). "Press Release: Siemens Plans to List Siemens Healthineers on Frankfurt Stock Exchange". Munich.

Region Region Frankfurt am Main
  Country Germany
Organisations Organisation Siemens Healthineers AG
  Group Siemens (Group)
  Organisation 2 Siemens AG
  Group Siemens (Group)
Products Product MedTech (medical technology)
  Product 2 investment banking
Index term Index term Siemens–OTHER: investment, 2018H1 PLANNED listing of newSiemens Healthineers AG at Frankfurt Stock Exchange
Persons Person Sen, Michael (Siemens 201711 Manamgent Board Member)
  Person 2 Thomas, Ralf P. (Siemens 201711 CFO)
     


Siemens AG is preparing to list its separately managed healthcare unit on the Prime Standard segment of the Frankfurt Stock Exchange's Regulated Market. This move, which the company's Supervisory Board approved at its meeting today, is planned for the first half of 2018. "For Siemens Healthineers, the public listing is the next logical step and the foundation for expanding our strong position as a leading global supplier of healthcare technology," said Michael Sen, Chairman of the Siemens Healthineers Supervisory Board and the member of Siemens' Managing Board responsible, among other things, for healthcare technology.

"Frankfurt is one of the world's largest trading centers for securities, and its importance will continue to increase due to Brexit. As a highly liquid trading venue, Frankfurt is attractive for investors from around the world. The public listing will give Siemens Healthineers entrepreneurial flexibility and access to the capital market. The goal is to grow sustainably and profitably while actively shaping the paradigm shift in the healthcare industry," said Michael Sen.

For the public listing, Siemens Healthineers AG will be established. "Our preparations for the public listing are completely on schedule. The Strategy 2025 concept and the management team are in place. The legal prerequisites have largely been fulfilled. Deutsche Bank, Goldman Sachs International and J.P. Morgan have been engaged as global coordinators, and BNP PARIBAS, BofA Merrill Lynch, Citigroup and UBS Investment Bank as further syndicate banks," said Siemens Chief Financial Officer Ralf P. Thomas.


Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for 170 years. The company is active around the globe, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of efficient power generation and power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2017, which ended on September 30, 2017, Siemens generated revenue of €83.0 billion and net income of €6.2 billion. At the end of September 2017, the company had around 372,000 employees worldwide. Further information is available on the Internet at www.siemens.com.

Reference Number: PR2017110102COEN


Link to this Press Release
www.siemens.com/press/PR2017110102COEN

Links
Website: Siemens Healthineers

@siemens_press
Follow us on Twitter


Contact

Mr. Robin Zimmermann
Siemens AG
Werner-von-Siemens-Straße 1
80333 Munich
Germany
Tel: +49 (89) 636-22804
r.zimmermann@siemens.com

Mr. Richard Speich
Siemens AG
Werner-von-Siemens-Straße 1
80333 Munich
Germany
Tel: +49 (89) 636-30017
richard.speich@siemens.com


   
Record changed: 2017-12-17

Advertisement

Picture [iito] – Putting Information into Context 600x102px

More documents for Siemens (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture BioM Forum Translational Medicine 2018 Würzburg Germany 600x60px




» top